Age, years (mean ± SD)
|
59 ± 12
|
61 ± 13
|
64 ± 14
|
36 ± NA
|
Median BMI, kg/m2 (min, max)
|
30 (25, 79)
|
30 (23, 49)
|
23 (18, 36)
|
34
|
Male sex, n (%)
|
7 (41)
|
5 (56)
|
1 (33)
|
1 (100)
|
Ethnicity, n (%)
|
White
|
8 (47)
|
5 (56)
|
1 (33)
|
0
|
Black or African American
|
7 (41)
|
3 (33)
|
1 (33)
|
1 (100)
|
Asian
|
0
|
1 (11)
|
1 (33)
|
0
|
Others/multiple
|
2 (12)
|
0
|
0
|
0
|
Hispanic or Latino, n (%)
|
2 (12)
|
1 (11)
|
0
|
0
|
Diabetes, n (%)
|
8 (47)
|
2 (22)
|
2 (67)
|
0 (0)
|
Hypertension, n (%)
|
8 (47)
|
4 (44)
|
2 (67)
|
0 (0)
|
Median time from the onset of symptoms to randomization, days (min, max)
|
9 (4, 34)
|
7 (4, 11)
|
11 (8, 17)
|
13
|
Ferritin, ng/mL (mean ± SD)
|
709 ± 553
|
772 ± 742
|
1776 ± 722
|
2151 ± NA
|
CRP, mg/dL (mean ± SD)
|
10 ± 7
|
12 ± 6
|
14 ± 11
|
9 ± NA
|
PaO2/FiO2 (mean ± SD)
|
178 ± 74
|
168 ± 78
|
106 ± 45
|
87 ± NA
|
PaO2/FiO2 ≥ 201
|
7 (41)
|
3 (33)
|
0
|
0
|
PaO2/FiO2 101–200
|
6 (35)
|
4 (44)
|
2 (67)
|
0
|
PaO2/FiO2 ≤ 100
|
4 (24)
|
2 (22)
|
1 (33)
|
1 (100)
|
PaO2/FiO2 101–200 ferritin ng/mL (mean ± SD)
|
867 ± 712
|
910 ± 1090
|
1637 ± 963
|
NA
|
PaO2/FiO2 101–200 CRP mg/dL (mean ± SD)
|
11 ± 5
|
13 ± 9
|
16 ± 15
|
NA
|